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1. Introduction: Thin polymeric film in nanomedicine 
 
An important and exciting direction of research in nanomedicine would be to gain a fundamental 
understanding of how living cells respond to nanostructures. At this aim, thin film technology plays 
a key role in helping to understand the cell-surface interactions. 
Generally, thin films are deposited onto bulk materials to achieve properties unattainable or not 
easily attainable in the substrate alone. In particularly, in biomedicine, polymeric thin films are used 
such as coating to improve the properties of biocompatibility, thus avoiding typical inflammatory 
response of immunitary system, especially when the system have to be permanently  implanted 
(Jeong et al., 1986). 
Various biodegradable polymeric drug delivery devices have been developed for the sustained 
release of a variety of drugs, which include micro and nanoparticles, films, foams, wafers, discs, and 
micro- and nanofibers (Jain, 2000) Among them, films have gained growing interest in various 
applications.(Dorta et al., 2002; Jackson et al., 2002; Perugini et al., 2003; Dhanikula et al. 2004 ; Jackson 
et al. 2004; Grant et al., 2005; Alexis et al. 2005; Westedt et al., 2006; Heller et al.1980). For example, 
films for stent applications have been devoleped to prevent early and late complications such as 
thrombotic closure and restenosis, that have been reported with all current metallic stent devices. 
(Westedt et al. 2006; Drachman et al. 2000; Alexis et al 2004,Hanefeld et al. 2006). The surfaces of most 
metals are electropositively charged and, therefore, are thrombogenic because blood elements are 
negatively charged. So the drawbacks of metallic stents have encouraged significant efforts to explore 
other materials as possible stent matrices. Alexis and colleagues studied the in vitro release kinetics of 
two important antirestenosis drugs: paclitaxel and rapamycin from biodegradable stent matrices. The 
poly(lactic-co-glycolic acid) (PLGA) and poly-DL-lactic acid (PDLLA) were selected in view of their 
relatively fast degradation rates (Alexis et al., 2006). 
Many polymer-based implantable film formulation were developed to provide controlled, local 
release of drug for the treatment of tumors (Ho et al, 2005). Local administration of chemotherapeutic 
agents has been investigated for the treatment of various cancers, such as brain, prostate, esophageal, 
head and neck, ovarian, and breast cancer (Jeong et al., 1986; Webber et al., 1998; Zhou et al., 1998; 
McCarron et al., 2000) . The implantation of a polymer-based device containing anti-cancer drug can 
provide a high-dose of chemotherapy to a specific area for a prolonged period of time (McCarron et 
al. 2000). The goal of Grant and collaborators, for example, was to develop a delivery system that 
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would benefit from the properties of chitosan and egg phosphatidylcholine lipids, while providing a 
sustained release of therapeutically effective levels of a hydrophobic agent, paclitaxel, over several 
months (Grant et al.,2005). 
The specific combination of chitosan and egg phosphatidylcholine was found to produce films with a 
minimal degree of swelling and high stability. The chitosan lipid blend serves as the matrix for the 
delivery system, and the drug is incorporated into nanoparticles that are dispersed throughout the 
film. This film with high degree of biocompatibility was found to be a promising system for the 
localized delivery of the highly lipophilic anticancer agent. 
Another typical application of thin polymeric film in biomedicine is to prevent post surgical 
adhesions. Postsurgical adhesions are abnormal tissue attachments that may result from tissue 
abrasion during surgical procedures. Shi et al. studied biodegradable polymeric film formulations for 
the controlled delivery of paclitaxel as an effective inhibitor of the formation of postsurgical 
adhesions (Shi et al., 2004). The films were intended to provide both a barrier effect to separate 
traumatized tissues and also to release paclitaxel to inhibit adhesion processes.  
 
2. Neural interfaces and drug delivery system 
 
From the rapid growth in biotechnology, neural engineering has emerged as a new field. The 
merging of neurophysiology and engineering has resulted in approaches to link brain activity with 
man-made devices to replace lost sensory and motor function (McGee et al., 2009). The excitement in 
this field is based not only on the prospect of helping a wide range of patients with neural disorders, 
but also on the certainty that this new technology will make possible to gain scientific insight into the 
way populations of neurons interact the complex, distributed systems that generate behaviour. 
After analytical demonstration of nerve excitation and associated action potential generation by Alan 
Hodgkin and Andrew Huxley in 1952, the possibility of using electrical phenomenon to cure diseases 
and to understand the principles of electrical nerve signals have been investigated through 
implementation of neural interfaces. 
Neural prosthetics are devices that link machines to the nervous system with the purpose of restoring 
lost functions. Two broad approaches are used in this field: neurons are stimulated or inhibited by 
applied current, or their activity is recorded to intercept motor intention. Stimulation can be used for 
its therapeutic efficacy, as in deep brain stimulation, to ameliorate the symptoms of Parkinson's 
disease or to communicate input to the nervous system (for example by transforming sound to neural 
input with cochlear prosthetics). In contrast, recordings are used to decode ongoing activity for use as 
a command or input signal to an external device (Schwartz et al., 2006). 
A great number of neuro-prostheses use interfaces with peripheral nerves or muscles for 
neuromuscular stimulation and signal recording. Only in this way, these new artificial devices can be 
easily incorporated into the natural control strategies of the subjects and can be felt as parts of their 
own body thanks to the sensory feedback which can be delivered from the sensors embedded in the 
robotic artefact to the nervous system. 
According to Navarro et al. 2005, a neural interface can be defined, from an engineering point of view, 
as a bidirectional transducer that establishes a contact between an artificial device and a neural 
structure within the body. On the other hand from a biological point of view, an interface is just a 
”foreign body”. These two aspects (the engineering and the biological) must be both taken in high 
consideration and an optimized invasive neural interface is a compromise between the two 
requirements. 
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The biocompatibility is the first and most important requirement for a neural interface. In general, the 
compatibility between a technical and a biological system can be divided into the structural 
biocompatibility and the surface biocompatibility (Bronzino et al. 1985). 
 
? The structural biocompatibility depends on the mechanical properties of the surrounding 
tissue and on the adaptation capability of the artificial material structure to the tissue. 
Device design and material properties should mimicry the biological structure of the target 
tissue. 
? The surface biocompatibility deals with the interaction of the chemical, physical, biological 
and morphological surface properties of the foreign material and the target tissue with the 
desired interaction. 
 
Several interfaces have been developed during the past years by many groups, applied both to the 
central nervous system (CNS, Schwartz 2004) and to the peripheral nervous system (PNS, Navarro et 
al., 2005).  
Notwithstanding the efforts carried out by several groups, the solutions developed so far suffer from 
several limitations which make very difficult the development of effective bionic systems. For 
example, cuff – and epineural - electrodes (Tarler et al., 2004) are reliable and robust, imply a reduced 
invasiveness, can be used to extract interesting information but suffer from a limited selectivity which 
is a significant drawback especially to deliver a sensory feedback. Intraneural PNS interfaces 
characterized by needles to be inserted longitudinally (LIFE electrodes, Lawrence et al.,2004) or 
transversally (USEA electrodes, McDonnall et al.,2004) into the PNS are very interesting combining a 
reduced (even if not absent) invasiveness with a good selectivity but their ”bandwidth” (i.e., the 
amount of information which can be exchanged between the natural and artificial systems) is still 
limited. 
Moreover, the use of these devices, and in particular microfabricated neural prostheses, is limited due 
to an inflammatory tissue reaction following implantation, which quickly degrades the stimulation 
and recording features of the device (Polikov et al., 2005). 
To avoid this phenomenon, several groups addressed their study to novel neuronal interfaces able of 
promoting neural regeneration. Anyway, the reactive tissue response of the brain to chronically 
implanted materials remains a formidable obstacle to stable recording from implanted 
microelectrodes. 
Over the course of days and weeks following implantation, a sheath of activated glia forms around 
the electrode, isolating the implanted device from the neuronal tissue (Szarowski et al., 2003). Studies 
have reported a “kill zone” around implanted devices where  neuronal cell bodies and fibers become 
severely reduced in density up to 200 µm around the implantation site (Biran et al., 2005). The reactive 
tissue response includes both an acute phase, caused by implantation injury, and a chronic response 
of the tissue to the implanted material itself (Polikov et al., 2005). The tissue response results in a 
decline in availability of viable neurons for recording, and a reduction in signal to noise ratio over 
time, which reduces or eliminates the ability to effectively collect recordings (Vetter et al., 2004). 
Two strategies are possible for improving the tissue response to invasive neural interfaces: to increase 
the structure biocompatibility and/or the surface biocompatibility.  
The first aspect can be achieved by the introduction of flexible interfaces. The inflammation at the 
implantation sites is thought to be aggravated by the mechanical mismatch between the stiff interface 
and the soft biological tissue. Their different mechanical properties induces relative drifts between 
the interface and the tissue encouraging the formation of a glial scar, which can encapsulate or break 
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the probe with time (Cheung et al. 2006).  Among the other materials, the polyimide has been having 
a great success for the development of neural interfaces as substrate for metal active sites and tracks. 
because of its high flexibility (Young’s  modulus between 4 and 10 GPa). If compared with silicon and 
silicon insulation (SiO2, Si3N4), it got a similar insulation resistance and dielectric strength at a lower. 
Polyimide is proved as a non-toxic material in biomedicine (Richardson et al. 1993) In addition, 
polyimide-based neural interfaces can be processed by thin film technologies which ensure high 
precision and repeatability, allows a variety of designs suitable for implantation in different nerves 
and anatomical regions, and a higher number of active sites can be positioned within a small surface 
(Stieglitz et al. 2005). As an example, polyimide-based regenerative electrodes with a thin film 
structure have been allowed for much better regeneration than silicon dice (Lago et al. 2005) while the 
tf-LIFE (thin film LIFE base on polyimide) demonstrated a good compromise between invasiveness 
and selectivity (Lago et al. 2007).  
From the other hand, alternative strategies are focusing also on the enhancement of surface 
biocompatibility. Local drug delivery to the region surrounding the implant as a means to avoid 
tissue response phenomena is actively pursued by several groups. The basic idea is to release 
bioactive components from a polymer coating on the electrode to the damaged neurons in order to 
induce adhesion and regeneration.  
Cue et al. used electrochemical polymerization to optimize the surface of the metal electrode sites. 
Poly(3,4-ethylenedioxythiophene) (PEDOT)/poly(styrene sulfonate) (PSS) was electrochemically 
deposited on the microelectrodes of neural probes (Cue et al., 2003). The PEDOT/PSS coating 
decreases the impedance modulus and, moreover, in comparison to a previous study on polypyrrole, 
PEDOT demonstrated much better electrochemical stability (Cui et al, 2001). A bioactive peptide was 
incorporated in the PEDOT film during the electrochemical polymerization to be released during the 
in vitro tests. The coated probes were cultured with rat glial cells that grew on the coating area of the 
probes and high quality acute neural recordings was obtained through the coated electrodes. 
One of the limits of the use of polymer surface coating is the increasing of dimensions of the device, 
potentially adding a layer to the surface that could range from tens to hundreds of micrometers in 
thickness. The high surface area-to-volume ratio of the coatings may reduce the ability for sustained 
delivery over long periods of time, which could minimize its potential for limiting the chronic 
neuroinflammatory response. 
To overcome these disadvantages, Williams et al., presented a method for targeted microscale drug 
delivery, based on micromachined “wells” fabricated into the substrate of a MEMS (micro-electro-
mechanical systems)- based chronic implant (Williams et al., 2005). These wells are holes that extend 
through the device thickness and allow for the integration of matrices (i.e., hydrogels) infused with 
bioactive substances. 
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Fig.1. Illustration of electrode well seeding technique. Schematics of the device and pipette 
depicting the injection and the droplet deposition methods prior to gel loading are given in (A) 
and (B), respectively, (C) schematic of a device with a filled well, (D) fluorescent image of probe 
immediately after the gel loading and subsequent withdrawal of pipette tip. The edges of the 
probe appear red due to internal reflection of the fluorescent DiI emanating from the well through 
the polyimide substrate. The volume of gel contained within the well is approximately 9 pL based 
on the well dimensions and (E) shows a polyimide based electrode with a seeded well in the 
middle of a tetrode arrangement of recording sites. 
 
Since the matrices replace the substrate instead of adding to it, the device footprint is not increased. 
The lower surface area-to-volume ratio lends the technique to extended time release periods. Another 
benefit arises from the possibility of inducing cellular growth through the holes, which, if achievable, 
may serve to physically anchor the implant into the surrounding tissue. Particularly for electrically-
based probes, any reduction of device movement post-implantation would aid in the localization of 
electrical signals and their subsequent assignment to individual cells. 
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Fig.2 Wells seeded with NGF. The upper left schematic (A)  illustrates the layout of an implanted 
microelectrode array, showing the relative position of the NGF-seeded well in relation to a recording 
site. In this four-shank implant, only one of the shanks has an NGF-seeded well. The implanted 
animal was sacrificed after 40 days, sectioned at the level of the NGF-seeded well, and 
immunohistochemically stained with antibodies against GFAP and the extracellular matrix protein, 
laminin. (B)  is a histological image from this implant. The site that contained the NGF-seeded well 
(second from the left in this image) showed increased levels of matrix deposition versus the unseeded 
electrode shank sites. (C) shows the electrophysiological recordings taken from two individual 
electrode sites closest to two different seeded wells, each at 40-days post-implantation.  
 
Qualitative observations depicted in Fig. 2B show a notable tissue response in the form of laminin 
deposition, seen as a green “cloud” over and adjacent to the site of NGF release from the gel. 
Additionally, an increased level of GFAP expression (yellow stained cells) can be seen around the 
implant sites. These results are typical for the sites of NGF seeding, but noticeably different from the 
well sites without NGF, which all showed a relatively normal response. A two-second sample of the 
extracellular recordings taken from two different recording sites, each located 15 µm from two 
different seeded wells is given in Fig. 2 C. These recordings demonstrate that the sites near the NGF-
seeded wells remain electrically viable following implantation. The recordings are typical for the sites 
adjacent to the NGF-seeded wells, although non statistically different from the other sites in the array. 
In all animals implanted with functioning electrodes (n = 4, 48 hours and 40 days), neural signals 
were recorded from the sites adjacent to the wells that had been seeded with bioactive molecules. 
Qualitatively, the electrodes were able to record unit activity with acceptable signal amplitude. 
Winter et al., have investigated the use of biodegradable, neurotrophin-eluting hydrogels (i.e., 
poly(ethylene glycol)-poly(lactic acid), PEGPLA) as a means of attracting neurites to the surface of 
stimulating electrodes. PEGPLA hydrogels with release rates ranging from 1.5 to 3 weeks were 
synthesized (Winter et al, 2007) . PEGPLA was selected because of the unique properties of the 
individual components. PEG has been shown to improve immune response to implanted elements  
and has been used to increase the circulation time of drugs. Thus PEG as a hydrogel component may 
reduce immune reaction to the implanted prosthesis and increase the circulation time of released 
neurotrophins associated with degrading PEG molecules. The PLA portion of the polymer provides 
biodegradability, allowing for eventual elimination of the polymer from the array. Additionally, the 
degradation rate can be used to regulate neurotrophin release through variations of the PEGPLA 
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ratio. These hydrogels were applied to multielectrode arrays with sputtered iridium oxide charge-
injection sites. PC12 cell cultures were exposed to NGF-releasing boluses, suspended in trans well 
inserts for 5/14 days, and compared to a positive control receiving 50 ng/mL of NGF, to a negative 
control receiving no NGF, and a to sham receiving BSA-releasing boluses. 
 
 
Fig.3 (A-E) Representative optical micrographs of PC12 Cells after 5 days with boluses in culture. (A) 
Positive control receiving 50 ng/mL NGF, (B) and (C) substrates display large numbers of neurites 
(arrows), whereas (D) negative control receiving 0 ng/mL NGF and (E)  sham, BSA-releasing bolus 
display only few, short neurites. 
 
 
The results of this work show that PEGPLA polymers can produce controlled, sustained release of 
neurotrophins, and that these neurotrophins produce neurite extension in a neuronal cell culture 
model. 
It was also verified that these hydrogels can be applied to electrically stimulating neural prostheses, 
and do not impede the function of these devices. Thus, neurotrophin-eluting hydrogels provide one 
possible means to attract neurites to an electrical prosthesis surface, potentially lowering electrical 
stimulation thresholds. If lower thresholds can be achieved, larger numbers of electrodes could be 
driven with the same power requirements, increasing pixel density. These high density devices will 
lead to greatly improved fidelity in electrically evoked sensory and functional responses. 
Recently, Pierce et al used another approach to mitigate the reactive tissue response of the brain to 
chronically implanted materials. A bioactive coating in the form of an ultra-porous silica sol–gel was 
applied on the surface of silicon-based microelectrodes (Pierce et al., 2009). The sol–gel technique 
allows for application of thin films of ultraporous silica, the morphology of which is characterized as 
a flat surface with pore size and surface features <25nm (Jedlicka et al., 2005). The films have a 
thickness of approximately 100 nm. These ultra-porous sol–gel thin films have been shown to be 
excellent substrates for neuronal growth (Jedlicka et al., 2006, 2007a). 
In Pierce’s study the attention was centred on two features of the microelectrode: the adherence of the 
coating and the resultant changes in electrical properties. Sol–gel presence and uniformity on the 
probes were assessed by the preparation of a fluorescently labelled coating that was revealed by 
fluorescence micrographs. 
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Fig.4. Microscopy confirms the adherence of sol–gel coatings to microelectrodes. (A) Bright field 
image of probes shows their location. (B) Fluorescent micrograph of coated probes. For the right 
probe, fluorescein salt was added to the precursor sol and was encapsulated throughout the coating. 
The left probe was coated in an unlabeled sol–gel as a control. The fluorescence of the right probe 
confirms coating adhesion.  These images demonstrate that the silica sol–gels can be successfully 
applied to silicon-based microelectrodes and Winter confirm the ability to encapsulate molecules in 
the TMOS precursor to enable drug delivery to the implantation site. 
 
To evaluate the stability of the coating an established agarose brain model was used: the coating 
appeared unaltered after insertion into the model, demonstrating adherence of the coating to the 
probe, that experiences similar mechanical stresses during surgical insertion. 
Another important evaluation concerns the electrical properties of the microelectrode. Without 
favourable electrical properties, a coating designed to mitigate the reactive tissue response would be 
of little value. The cyclic voltammetry study demonstrated that the dip-coated, ambient-dried thin 
film silica sol–gel coatings do not adversely affect the electrical characteristics of the implantable 
electrodes, and it may in fact provide beneficial electrical properties. A major advantage of the sol–gel 
produced silica is a wide versatility for biofunctionalization. All together, these features will allow the 
sol–gel silica coatings to be used as a platform material for the mitigation of the chronic phase of the 
reactive tissue response, without causing significant detriment to the functionality of the probes. 
Green et al led a study on modified laminin peptides DEDEDYFQRYLI and DCDPGYIGSR. used to 
dope poly(3,4-ethylenedioxythiophene) (PEDOT) electrodeposited on platinum (Pt) electrodes (Green 
et al, 2008).  
DCDPGYIGSR was chosen due to positive results reported by Cui et al. (Cui et al, 2003) 
DEDEDYFQRYLI, a peptide which has not previously been incorporated into conducting polymers, 
was also assessed. This peptide contains the active sequence YFQRYLI, identified by Tashiro et al. and 
reported to mediate cell attachment and promote neurite outgrowth in both PC12 cells and cerebellar 
microexplant cultures (Tashiro et al, 1998). The effect of a large biomolecule dopant on conducting 
polymer physico- chemical properties was established with comparison to conventionally doped 
PEDOT/paratoluene sulfonate (pTS). 
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Fig.5. SEMs at 15,000x magnification: (A) PEDOT/pTS; (B) PEDOT/DEDEDYFQRYLI; (C) 
PEDOT/DCDPGYIGSR 
 
The resulting film was less homogeneous in microscopic appearance than the control PEDOT/pTS 
film. Doping PEDOT with laminin peptides, DEDEDYFQRYLI and DCDPGYIGSR, resulted in altered 
formation of the polymer during electrodeposition. 
The use of large synthetic peptides as anionic dopants produced a softer interface with improved 
impedance characteristics, especially in the low frequency, biologically significant, region. However, 
reduced polymer electrochemical stability and lower adherence of the films to the Pt electrode was 
observed when compared to the conventionally doped pTS control. The larger DEDEDYFQRYLI 
dopant was shown to reduce the efficiency of electropolymerisation and consequently this polymer 
presented lower mechanical adherence than the DCDPGYIGSR-doped PEDOT. 
The effect of peptide doped polymers on mammalian cell interactions and the cell response to 
peptides containing specific bioactive ligands was assessed using the neural-like PC12 cell line. 
 
 
Fig.6. Sample images of PC12 neurite outgrowth on PEDOT at 96 h post-plating with bare polymer 
(top) and adsorbed whole laminin coated polymer (bottom): A. PEDOT/pTS; B. 
PEDOT/DEDEDYFQRYLI; C. PEDOT/DCDPGYIGSR. 
 
Uncoated DEDEDYFQRYLI-doped PEDOT appears to support higher neurite outgrowth per cell than 
both PEDOT/pTS and PEDOT/DCDPGYIGSR despite having the lowest density of attached cells. 
PEDOT/ DCDPGYIGSR also presented a greater neurite outgrowth per cell than the PEDOT/pTS 
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control. All polymers showed a significant improvement in cell attachment and growth compared to 
the conventional Pt electrode. 
 
3. A case study: alginate coated CNT array 
 
Carbon nanotubes (CNTs) are molecular-scale tubes of graphitic carbon with outstanding properties. 
They are among the stiffest and strongest fibers known, and have remarkable electronic properties 
and many other unique characteristics. For these reasons they have attracted huge academic and 
industrial interest, with thousands of papers on nanotubes being published every year (Ciofani et al., 
2009). 
 More recently, nanotubes formed from conductive polymers have been applied to electrode sites, 
both reducing site impedance and providing a platform for controlled drug release (Abidian et 
al.,2006; Abidian and Martin, 2008). Although many of these methods are promising, none have 
emerged as a definitive solution to the problem of reactive tissue response. 
The case study presented in this Section is a combination of a polymer technology and carbon 
nanotubes array for the development of a drug delivery system at cellular level. Starting from these 
preliminary results, it is possible obtain innovative neural interface that combine the electrical 
properties of carbon nanotubes with the advantage of a drug delivery system, to avoid the typical 
response of the immunitary system. 
Recently, the use of carbon nanotubes (Tasis et al, 2006) attracted significant attention of several 
groups for the development of novel neuronal interfaces (Nguyen et al, 2007 Nguyen et al 2006,Gabay 
et al, 2007). Composite materials containing multi-walled CNTs have shown the ability to limit 
astrocyte production of glial scarring, while maintaining good neuronal connections (McKenzie et al, 
2004). 
Nguyen and collaborators found that PC12 cells cultured on PPy-coated CNT arrays (treated with a 
thin layer of collagen to promote cell adhesion) can form extended neural network upon 
differentiation  Starting from these considerations, in our laboratory we have proposed a combination 
of drug delivery system with such CNT array, exploiting a thin film of calcium alginate as drug 
reservoir embedded into the platform. 
Two in vitro assays have been performed to validate the protein release on two cell lines: CrFK  and 
PC12 cell, a cell line derived from a transplantable rat pheochromocytoma that respond reversibly to 
NGF by inducing a neuronal phenotype. In its presence, these cells undergo a dramatic change in 
phenotype whereby they acquire most of the characteristic properties of sympathetic neurons.  The 
polymeric film embedded in the CNT array is described and characterized in terms of release kinetics 
using bovine serum albumin as drug model.  
 
 
Fig.7: Schematic illustration of the proposed CNT based system 
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Figure 7 represents the scheme of the proposed system. The main structure is composed by the CNT 
array, embedded with a thin film of alginate entrapping the drug. 
 
 
Fig.8 FIB image of the as-grown CNT array 
 
The as-grown CNT array is not stable when treated in liquid environments: during the drying 
process, CNTs irreversibly stick together to form microbundles, driven by the capillary force of water 
droplets (Figure 8). In order to avoid this phenomenon, a double approach was followed: SiO2 film 
was deposited via sputtering in order to prevent the CNT sticking in a liquid environment, and to 
improve mechanical features of CNTs. A thin layer of a conductive polymer, polypirrole, was 
deposited by electrochemical deposition in order to reduce the impedance of the system and to 
improve the recording.  
This phenomenon is completely avoided by performing an SiO2 coating. The SiO2 thin film, in fact, 
improves CNT mechanical features against the capillary force of water droplets during the drying 
process, thus preserving vertically alignment (Fig. 9b). The thin film of polypirrole partially avoided 
the problem, but it was not found satisfactory. 
 
a b c
 
Fig.9 Bare (a), PPy-coated (b), and SiO2-coated (c) CNT array (samples dipped in water and dried in 
air before the imaging) 
 
Among polymers, alginate has several unique properties that have allowed to use it as a matrix for 
the entrapment and/or delivery of a variety of biological agents (Chretien et al, 2005). It is a co-
polymer extracted from some types of brown algae, and it is made up of two uronic acids: D-
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mannuronic acid and L-guluronic acid. Polyvalent cations are responsible for interchain and 
intrachain reticulations because they are tied to the polymer when two guluronic acid residuals are 
close (Mikkelsen et al, 1995).  The reticulation process consists of the simple substitution of sodium 
ions with calcium ions (Gombotz et al,1998). The relatively mild gelation process has enabled not only 
proteins (Ciofani et al, 2008) but also cells (Murtas et al, 2005) and DNA (Kimberly et al.2006) to be 
incorporated into alginate matrices with full retention of the biological activity. 
For drug release kinetics investigation, BSA entrapped in the film was used as “protein model”, as its 
molecular weight is similar to that one of NGF and its concentration can be much more easily 
evaluated concentration in the release bulk via spectrophotometry. 
Crosslinking was thus performed with a 30% CaCl2 solution, gently stirred and quickly removed 
(Simpson et al. 2004).  
In order to define a thickness of the film polymer comparable to the height of CNTs, different alginate 
solutions at several concentration were tested, producing films on Si clean surface. Subsequently, via 
FIB analysis, the film thickness for the different conditions was measured, and finally the alginate 
concentration corresponding to a film thickness of approximately 5 µm was chosen. 
The typical temporal trend of the protein release from the alginate thin film is reported in Figure 10. 
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Fig.10 Alginate release profile: experimental data and model fitting (n =3). 
 
Protein amount is given as percentage of the initial amount entrapped into the film (200 µg per cm3 of 
film). The trend is well fitted (R2 =97,65%) with a bi-exponential curve as already reported for 
alginate fibers (Ciofani et al. 2008a) and microspheres (Ciofani et al., 2008b) and described by the 
following expression: 
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where C2 is the protein in the bulk, C10 is the concentration inside the gel, S and V1 are, respectively, 
the surface and the volume of film, V2 is the volume of the bulk, h is the massive exchange coefficient, 
Cs0 is the protein concentration on the surface of the film and finally ks is the desorption rate constant. 
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Substituting known values and by fitting the experimental data with the mathematical model of 
equation (1), the h value results 10-9 m/s, in agreement with data given in the literature for alginate 
microsphere (Laca et al, 1999). 
In vitro experiments were carried out on two cell lines: in preliminary assays feline nephritic 
fibroblasts (CrFK) were used just to validate the diffusion of the drug in the bulk and the up-take by 
the cells. Other salient responses to NGF include cessation of proliferation, generation of long 
neurites, acquisition of electrical excitability, hypertrophy and a number of changes in composition 
associated with acquisition of a neuronal phenotype (Greene et al., 1998) 
 
 
Fig. 11 Fluorescent microscopy of CrFK cells onto SiO2 (left) of PPy (right) coated CNT interface 
entrapping fluoscent BSA coniugate after six hours of incubation 
 
Figure 11 shows fluorescent microscopy images of CrFK cells after six hours of incubation onto CNT 
array coated with SiO2 and PPy, respectively. These results demonstrate that the FITC-BSA, 
embedded in the alginate film, is efficiently released and internalized by the cells. 
Alginate film coated on the CNT array and entrapping NGF was finally tested on PC12 cells 
monitoring their differentiation. An alginate solution  entrapping 2 nM of NGF was casted on the 
CNT array and thereafter crosslinked with a 30% CaCl2 solution as previously reported. PC12 cells 
were seeded on an ad hoc polystyrene substrate, fabricated with high precision milling machine, at a 
density of 50,000/cm2. The substrate was thereafter placed on the CNT array system and the cells 
were grown in differentiating medium. 
Figure 12 shows clearly differentiated PC12 cells after incubation on the CNT array coated with the 
releasing film. The microscope analysis was carried out up to three days of incubation, and, 
specifically, after 8 (Figure 12a), 24 (Figure 12b), 48 (Figure 12c) and finally after 72 hours (Figure 
12d). Number of differentiated cells incremented during the time: at the third day of culture, the 
PC12 cells generate a neural network, that is a clear demonstration that the NGF is released from the 
film and still maintained its bioactivity. 
 
 
Polymeric thin films 14 
 
Fig.12 Differentiating PC12 cells after 8 (a), 24 (b), 48 (c) and 72 h (d) 
Fig. 13a and 13b show, respectively, the percentage of differentiated cells and the neurite length at the 
different time points. Figure 6a shows that already after eight hour, a non negligible number of  cells, 
about the 10%, are differentiated. After 24 h there is a spread of the number of differentiated cells, 
about the 85% of the total cells. In the second day, the number increased up to 90% and, in the third 
day, about 96% of the cells presented well developed neurites. Figure 6b reports the trend of neurite 
length in the time: already after 24 hours, the mean length of the neurite is 30 ±17.9 µm and after 72 
hours the length increases up to 28 ±15.9 µm. 
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Fig.13 Percentage of differentiated cells (a) and neurite length (b)  vs. time (n = 3) 
 
These data do not significantly differ (p > 0.1, Student’s t-test) from control tests performed with 
“free” NGF (80 ng/ml in the culture medium) where, after three days of incubation, almost 95% of 
cell were differentiated with an average neurite length of about 30 µm. 
 
4. Conclusion 
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Drug delivery to the central nervous system (CNS) remains a challenge despite advances in 
understanding the mechanisms involved in the development of neurodegenerative disorders and the 
actions of neuroactive agents. Drug accessibility to the CNS is limited by the blood-brain barrier; 
moreover the systemic administration of neuroactive biomolecules to support neuronal regeneration 
has several intrinsic problems, including the toxicity and poor stability associated with many 
bioactive factors (Maysinger et al., 1997). 
A variety of techniques to deliver therapeutics to the CNS has been established, including osmotic 
pumps (Lewin et al., 1997) and silicone reservoirs. However, pumps frequently become clogged, thus 
limiting their ability to sustain effective concentrations; moreover these methods are often associated 
to highly invasive drawbacks, including device failure and higher potentials for inflammation and 
infection due to their non degradable components. Polymeric delivery systems have the potential to 
maintain therapeutic levels of a drug, to reduce side effects and to facilitate the delivery of drugs with 
short in vivo half-lives. 
In this Chapter we have outlined a different applications of polymers, usually intended  as agent 
acted to improve the biodistribution of the desired drugs. Namely, we have highlighted the huge 
possibilities offered by the thin film technology applied to the concepts of “drug delivery” and “drug 
targeting”. After a summary of the most relevant examples in the literature, we described the 
ongoing work in our lab, aimed at obtaining an efficient combination of physical and chemical 
features of an innovative neuronal interface based on a carbon nanotubes array. 
The achieved results indicate that polymer technology could be efficiently embedded in CNT array 
(Hind et al., 2004) acting as drug delivery system at cellular level. The implication of this study open 
several perspectives in particular in the field of neurointerfaces, combining several functions into a 
single platform  (Navarro et al., 1998; Navarro et al., 2005). 
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